Unity Biotechnology, Inc.
(NASDAQ : UBX)

( )
UBX PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen, Inc. 0.12%283.741.5%$847.25m
GILDGilead Sciences, Inc. 0.98%86.261.0%$795.01m
MRNAModerna, Inc. -0.23%176.400.0%$769.19m
VRTXVertex Pharmaceuticals, Inc. -1.01%312.981.9%$482.01m
REGNRegeneron Pharmaceuticals, Inc. 0.12%736.232.6%$473.28m
BIIBBiogen, Inc. 0.56%305.151.8%$355.07m
ILMNIllumina, Inc. -1.39%218.993.2%$270.73m
SNSSSunesis Pharmaceuticals, Inc. 5.70%2.780.7%$194.33m
BMRNBioMarin Pharmaceutical, Inc. -0.89%96.924.2%$161.47m
BNTXBioNTech SE -0.88%154.850.0%$152.12m
MRTXMirati Therapeutics, Inc. 2.89%98.621.6%$132.21m
TECHBio-Techne Corp. 0.79%338.974.5%$123.89m
AXSMAxsome Therapeutics, Inc. 1.07%56.821.6%$80.71m
NVAXNovavax, Inc. -2.88%16.5475.3%$70.44m
HALOHalozyme Therapeutics, Inc. 0.59%54.6718.4%$64.50m

Company Profile

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.